Select Page

Contact IBC

Chair
Colleen McDermott
(920) 424-1217
IBC Administrator
Kelly Schill
(920) 424-3375
IBC Administration
(920) 424-3215
biosafety@uwosh.edu

Office located in Dempsey Hall Suite 214

Quick Look

Tax ID: 39-1805963
DUNS: 071149041
Cage/NCAGE code: 0M5A5
Cong. District: WI-006
Cognizant Federal Agency:
Dept. of Health and Human Services
F&A Rates: 38.5% on campus; 13% off campus

Fringe Rates CLICK HERE

Mailing Address:
University of Wisconsin Oshkosh Office of Sponsored Programs & Faculty Development
800 Algoma Blvd.,
Dempsey Hall 214
Oshkosh, WI 54901-8610

General Inquiry:

Phone: 920-424-3215
Fax: 920-424-3221

Need More?

The mission of the Institutional Biosafety Committee (IBC) at the University of Wisconsin Oshkosh is to ensure, regardless of funding, that activities with biohazardous materials are conducted safely and responsibly.  To fulfill this commitment, the IBC reviews and monitors all research and teaching activities by faculty, staff, and students that utilize biological infectious agents, toxins of biological origin, and recombinant or synthetic nucleic acid molecules.  The IBC will maintain compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) and will use the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 5th Edition, as an advisory guide.

Begin a Project utilizing Biohazardous Materials

The UW Oshkosh IBC is registered with NIH Office of Science Policy (OSP) and renews its institutional registration on an annual basis.

Researchers or instructors planning to utilize biohazardous materials in their research and/or teaching activities on campus must complete an IBC Risk Assessment form found on the IBC forms page and submit it to biosafety@uwosh.edu.  Materials that will be subjected to an initial review by the IBC include biological agents, toxins of biological origin, and recombinant or synthetic nucleic acid molecule work.  The IBC Risk Assessment form must be submitted to the IBC for an initial review and determination of risk.  The IBC Chairperson may suggest submission of additional documents subsequent to the Risk Assessment, as needed, to accurately portray the intended scope of work.  UW Oshkosh IBC has established an institutional policy to perform a review of all proposed work, even if the work involves recombinant or synthetic nuclear acid molecules is determined to be Exempt from the NIH Guidelines.  Activities involving biological agents and biological toxins are also registered with the IBC to ensure safety of procedures for personnel.

At this time UW Oshkosh does not have the facilities available to conduct activities working with Risk Group 3 or higher.

The mission of the Institutional Biosafety Committee (IBC) at the University of Wisconsin Oshkosh is to ensure, regardless of funding, that activities with biohazardous materials are conducted safely and responsibly.  To fulfill this commitment, the IBC reviews and monitors all research and teaching activities by faculty, staff, and students that utilize biological infectious agents, toxins of biological origin, and recombinant or synthetic nucleic acid molecules.  The IBC will maintain compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) and will use the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 5th Edition, as an advisory guide.

Begin a Project utilizing Biohazardous Materials

The UW Oshkosh IBC is registered with NIH Office of Science Policy (OSP) and renews its institutional registration on an annual basis.

Researchers or instructors planning to utilize biohazardous materials in their research and/or teaching activities on campus must complete an IBC Risk Assessment form found on the IBC forms page and submit it to biosafety@uwosh.edu.  Materials that will be subjected to an initial review by the IBC include biological agents, toxins of biological origin, and recombinant or synthetic nucleic acid molecule work.  The IBC Risk Assessment form must be submitted to the IBC for an initial review and determination of risk.  The IBC Chairperson may suggest submission of additional documents subsequent to the Risk Assessment, as needed, to accurately portray the intended scope of work.  UW Oshkosh IBC has established an institutional policy to perform a review of all proposed work, even if the work involves recombinant or synthetic nuclear acid molecules is determined to be Exempt from the NIH Guidelines.  Activities involving biological agents and biological toxins are also registered with the IBC to ensure safety of procedures for personnel.

At this time UW Oshkosh does not have the facilities available to conduct activities working with Risk Group 3 or higher.

Contact IBC

Chair
Colleen McDermott
(920) 424-1217
IBC Administrator
Kelly Schill
(920) 424-3375
IBC Administration
(920) 424-3215
biosafety@uwosh.edu

Office located in Dempsey Hall Suite 214

Quick Look

Tax ID: 39-1805963
DUNS: 071149041
Cage/NCAGE code: 0M5A5
Cong. District: WI-006
Cognizant Federal Agency:
Dept. of Health and Human Services
F&A Rates: 38.5% on campus; 13% off campus

Fringe Rates CLICK HERE

Mailing Address:
University of Wisconsin Oshkosh Office of Sponsored Programs & Faculty Development
800 Algoma Blvd.,
Dempsey Hall 214
Oshkosh, WI 54901-8610

General Inquiry:

Phone: 920-424-3215
Fax: 920-424-3221

Need More?